ClearSky at MDS 2025: Advancing AI and Digital Biomarkers for Movement Disorder Research  ClearSky Medical Diagnostics had the privilege of participating in the 2025 International Congress of Parkinson’s Disease & Movement Disorders (MDS)  in Honolulu, Hawaii (October 5–9) . This marked our eighth year  exhibiting at MDS, reflecting ClearSky’s long-standing commitment to advancing analytics and AI-driven insights in movement disorder research. The MDS Congress is the world’s